OSAM
AMAG

O'Shaughnessy Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-818
Closed -$11K – 1028
2017
Q4 		$11K Hold
818
– – ﹤0.01% 798
2017
Q3 		$15K Sell
818
-1,539
-65% -$28.7K ﹤0.01% 759
2017
Q2 		$43K Sell
2,357
-638
-21% -$12.6K ﹤0.01% 733
2017
Q1 		$68K Buy
+2,995
New +$71.7K ﹤0.01% 670

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

O'Shaughnessy Asset Management's AMAG Position: Q1 2018 in Review

O'Shaughnessy Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 818 shares — an estimated $11K sold.

O'Shaughnessy Asset Management first reported a position in AMAG in Q1 2017 and held it in 4 quarters. The position peaked at $68K in Q1 2017. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • O'Shaughnessy Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 818 AMAG Pharmaceuticals shares in Q1 2018, an estimated $11K.
  • O'Shaughnessy Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's AMAG Pharmaceuticals position peaked at $68K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2018, filed 8 May 2018.